Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial
- PMID: 22317944
- DOI: 10.1016/j.sleep.2011.11.010
Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial
Abstract
Background: Restless legs syndrome (RLS) is a common disorder in hemodialysis patients that leads to insomnia and impaired quality of life. Because high oxidative stress has been implicated in the pathogenesis of RLS, we sought to evaluate the efficacy of vitamins C and E and their combination in reducing the severity of RLS symptoms in hemodialysis patients in this randomized, double-blind, placebo-controlled, four-arm parallel trial.
Methods: Sixty stable hemodialysis patients who had all four diagnostic criteria for RLS developed by the International Restless Legs Syndrome Group with no acute illness or history of renal stone were randomly allocated to four fifteen-patient parallel groups to receive vitamin C (200 mg) and vitamin E (400 mg), vitamin C (200 mg) and placebo, vitamin E (400 mg) and placebo, and double placebo daily for eight weeks. International Restless Legs Scale (IRLS) scores were measured for all patients at baseline and at the end of treatment phase. The primary outcome was absolute change in IRLS sum score from baseline to the end of treatment phase.
Results: Means of IRLS sum score decreased significantly in the vitamins C and E (10.3 ± 5.3, 95% CI: 7.4-13.3), vitamin C and placebo (10 ± 3.5, 95% CI: 8.1-11.9), and vitamin E and placebo groups (10.1 ± 6, 95% CI: 6.8-13.5) compared with the double placebo group (3.1 ± 3, 95% CI: 1.5-4.8), (P<0.001); however, no differences were observed between these treatment groups.
Conclusions: Vitamins C and E and their combination are safe and effective treatments for reducing the severity of RLS in hemodialysis patients over the short-term.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.Clin Ther. 2013 Sep;35(9):1321-36. doi: 10.1016/j.clinthera.2013.06.016. Epub 2013 Aug 9. Clin Ther. 2013. PMID: 23938061 Clinical Trial.
-
Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.Am J Kidney Dis. 2016 Sep;68(3):434-43. doi: 10.1053/j.ajkd.2015.12.027. Epub 2016 Feb 3. Am J Kidney Dis. 2016. PMID: 26851201 Clinical Trial.
-
Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.Mov Disord. 2006 Oct;21(10):1627-35. doi: 10.1002/mds.21050. Mov Disord. 2006. PMID: 16874755 Clinical Trial.
-
Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.Brain. 2008 Apr;131(Pt 4):902-17. doi: 10.1093/brain/awm244. Epub 2007 Oct 11. Brain. 2008. PMID: 17932100 Review.
-
Restless legs syndrome in end-stage renal disease.Sleep Med. 2004 May;5(3):309-15. doi: 10.1016/j.sleep.2004.01.014. Sleep Med. 2004. PMID: 15165541 Review.
Cited by
-
Antioxidants for adults with chronic kidney disease.Cochrane Database Syst Rev. 2023 Nov 2;11(11):CD008176. doi: 10.1002/14651858.CD008176.pub3. Cochrane Database Syst Rev. 2023. PMID: 37916745 Review.
-
Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.Tremor Other Hyperkinet Mov (N Y). 2023 Mar 29;13:10. doi: 10.5334/tohm.752. eCollection 2023. Tremor Other Hyperkinet Mov (N Y). 2023. PMID: 37008995 Free PMC article. Review.
-
Five Things to Know About Restless Legs Syndrome in Patients on Dialysis.Can J Kidney Health Dis. 2023 Mar 23;10:20543581231164275. doi: 10.1177/20543581231164275. eCollection 2023. Can J Kidney Health Dis. 2023. PMID: 36994129 Free PMC article. No abstract available.
-
Demand for Water-Soluble Vitamins in a Group of Patients with CKD versus Interventions and Supplementation-A Systematic Review.Nutrients. 2023 Feb 8;15(4):860. doi: 10.3390/nu15040860. Nutrients. 2023. PMID: 36839219 Free PMC article. Review.
-
Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review).Exp Ther Med. 2022 Feb;23(2):185. doi: 10.3892/etm.2021.11108. Epub 2021 Dec 30. Exp Ther Med. 2022. PMID: 35069866 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical